HER-2 Targeted Drugs for Breast Cancer Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of HER-2 Targeted Drugs for Breast Cancer Market

1.3 Market Segment by Type

1.3.1 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab from 2016 to 2027

1.3.2 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pertuzumab from 2016 to 2027

1.3.3 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Lapatinib from 2016 to 2027

1.3.4 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Neratinib from 2016 to 2027

1.3.5 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab Emtansine from 2016 to 2027

1.3.6 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pyrotinib from 2016 to 2027

1.3.7 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Hospital from 2016 to 2027

1.4.2 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Clinic from 2016 to 2027

1.4.3 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Drug Center from 2016 to 2027

1.4.4 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of HER-2 Targeted Drugs for Breast Cancer by Major Types

3.4.1 Market Size and Growth Rate of Trastuzumab

3.4.2 Market Size and Growth Rate of Pertuzumab

3.4.3 Market Size and Growth Rate of Lapatinib

3.4.4 Market Size and Growth Rate of Neratinib

3.4.5 Market Size and Growth Rate of Trastuzumab Emtansine

3.4.6 Market Size and Growth Rate of Pyrotinib

3.4.7 Market Size and Growth Rate of Other

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of HER-2 Targeted Drugs for Breast Cancer by Major End-Users

4.4.1 Market Size and Growth Rate of HER-2 Targeted Drugs for Breast Cancer in Hospital

4.4.2 Market Size and Growth Rate of HER-2 Targeted Drugs for Breast Cancer in Clinic

4.4.3 Market Size and Growth Rate of HER-2 Targeted Drugs for Breast Cancer in Drug Center

4.4.4 Market Size and Growth Rate of HER-2 Targeted Drugs for Breast Cancer in Other

5.1 China HER-2 Targeted Drugs for Breast Cancer Production Analysis by Regions

5.2 China HER-2 Targeted Drugs for Breast Cancer Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

6.2 North China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

7.1 Central China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

7.2 Central China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

8.1 South China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

8.2 South China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

9.1 East China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

9.2 East China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

10.1 Northeast China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

10.2 Northeast China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

11.1 Southwest China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

11.2 Southwest China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

12.1 Northwest China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major Types

12.2 Northwest China HER-2 Targeted Drugs for Breast Cancer Landscape Analysis by Major End-Users

13.1 Novartis

13.2 Hetero Drugs

13.3 Chugai Pharmaceutical

13.4 Hengrui Medicine

13.5 GlaxoSmithKline

13.6 Beacon Pharmaceuticals Limited

13.7 Roche

13.8 Puma Biotechnology

13.9 CANbridge

13.10 Pfizer

Figure Product Picture

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pertuzumab from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Lapatinib from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Neratinib from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab Emtansine from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pyrotinib from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Hospital from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Clinic from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Drug Center from 2016 to 2027

Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of HER-2 Targeted Drugs for Breast Cancer Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of HER-2 Targeted Drugs for Breast Cancer

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of HER-2 Targeted Drugs for Breast Cancer by Different Types from 2016 to 2027

Table Consumption Share of HER-2 Targeted Drugs for Breast Cancer by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of Trastuzumab

Figure Market Size and Growth Rate of Pertuzumab

Figure Market Size and Growth Rate of Lapatinib

Figure Market Size and Growth Rate of Neratinib

Figure Market Size and Growth Rate of Trastuzumab Emtansine

Figure Market Size and Growth Rate of Pyrotinib

Figure Market Size and Growth Rate of Other

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of HER-2 Targeted Drugs for Breast Cancer by Different End-Users from 2016 to 2027

Table Consumption Share of HER-2 Targeted Drugs for Breast Cancer by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Hospital

Figure Market Size and Growth Rate of Clinic

Figure Market Size and Growth Rate of Drug Center

Figure Market Size and Growth Rate of Other

Table China HER-2 Targeted Drugs for Breast Cancer Production by Regions

Table China HER-2 Targeted Drugs for Breast Cancer Production Share by Regions

Figure China HER-2 Targeted Drugs for Breast Cancer Production Share by Regions in 2016

Figure China HER-2 Targeted Drugs for Breast Cancer Production Share by Regions in 2021

Figure China HER-2 Targeted Drugs for Breast Cancer Production Share by Regions in 2027

Table China HER-2 Targeted Drugs for Breast Cancer Consumption by Regions

Table China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Regions

Figure China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Regions in 2016

Figure China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Regions in 2021

Figure China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Regions in 2027

Table North China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table North China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure North China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table Central China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table Central China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure Central China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table South China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table South China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure South China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table East China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table East China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure East China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption by Types from 2016 to 2027

Table Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types from 2016 to 2027

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2016

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2021

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by Types in 2027

Table Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption by End-Users from 2016 to 2027

Table Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users from 2016 to 2027

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2016

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2021

Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Novartis

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

Figure Sales and Growth Rate Analysis of Novartis

Figure Revenue and Market Share Analysis of Novartis

Table Product and Service Introduction of Novartis

Table Company Profile and Development Status of Hetero Drugs

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hetero Drugs

Figure Sales and Growth Rate Analysis of Hetero Drugs

Figure Revenue and Market Share Analysis of Hetero Drugs

Table Product and Service Introduction of Hetero Drugs

Table Company Profile and Development Status of Chugai Pharmaceutical

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical

Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical

Figure Revenue and Market Share Analysis of Chugai Pharmaceutical

Table Product and Service Introduction of Chugai Pharmaceutical

Table Company Profile and Development Status of Hengrui Medicine

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hengrui Medicine

Figure Sales and Growth Rate Analysis of Hengrui Medicine

Figure Revenue and Market Share Analysis of Hengrui Medicine

Table Product and Service Introduction of Hengrui Medicine

Table Company Profile and Development Status of GlaxoSmithKline

Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

Figure Sales and Growth Rate Analysis of GlaxoSmithKline

Figure Revenue and Market Share Analysis of GlaxoSmithKline

Table Product and Service Introduction of GlaxoSmithKline

Table Company Profile and Development Status of Beacon Pharmaceuticals Limited

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beacon Pharmaceuticals Limited

Figure Sales and Growth Rate Analysis of Beacon Pharmaceuticals Limited

Figure Revenue and Market Share Analysis of Beacon Pharmaceuticals Limited

Table Product and Service Introduction of Beacon Pharmaceuticals Limited

Table Company Profile and Development Status of Roche

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

Figure Sales and Growth Rate Analysis of Roche

Figure Revenue and Market Share Analysis of Roche

Table Product and Service Introduction of Roche

Table Company Profile and Development Status of Puma Biotechnology

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Puma Biotechnology

Figure Sales and Growth Rate Analysis of Puma Biotechnology

Figure Revenue and Market Share Analysis of Puma Biotechnology

Table Product and Service Introduction of Puma Biotechnology

Table Company Profile and Development Status of CANbridge

Table Sales, Revenue, Sales Price and Gross Margin Analysis of CANbridge

Figure Sales and Growth Rate Analysis of CANbridge

Figure Revenue and Market Share Analysis of CANbridge

Table Product and Service Introduction of CANbridge

Table Company Profile and Development Status of Pfizer

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

Figure Sales and Growth Rate Analysis of Pfizer

Figure Revenue and Market Share Analysis of Pfizer

Table Product and Service Introduction of Pfizer